Trinity biotech announces entry into an increased loan facility to fund potential acquisitions

Dublin, ireland, feb. 22, 2023 (globe newswire) -- trinity biotech plc (nasdaq: trib) (the “company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced its entry into an increased loan facility to fund potential acquisitions and ongoing operations.
TRIB Ratings Summary
TRIB Quant Ranking